Gabe Kwong

Gabe Kwong began their career in 2009 as a Postdoctoral Fellow at MIT. In 2014, they joined the Georgia Institute of Technology as an Assistant Professor, where they were also the Director of the Laboratory for Synthetic Immunity (LSI). In 2015, they co-founded Glympse Bio and in 2022, they co-founded Port Therapeutics.

Gabe Kwong received their B.S. in Bioengineering from the University of California, Berkeley between 1998 and 2002. Gabe then went on to pursue a Ph.D. in Bioengineering at Caltech, which they completed in 2009.